About Conference
This meeting will showcase trailblazing approaches in the design and engineering of novel biologic modalities as linked to their pre-clinical development and selected early outcomes in the clinic.
Highlights
the topics covered will engage discussions around: antibody-based protein degraders; next-generation antibody drug conjugate technologies; precision biologics; increasing accessibility of antibody drugs on a global scale; advances in combination biology and modalities
Find on Map
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.
2.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
3.
Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer
4.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
5.
A new blood test greatly increases the ability to detect cancer.
1.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
2.
Unraveling the Mysteries of Hematocrit: How It Impacts Your Health
3.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
4.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
5.
Surprising Symptoms of Prostate Cancer: What You Need to Know
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
Recommended News For You
1.
Targeted Combination Shows Promise in Metastatic Kidney Cancer
2.
Prostate Cancer Treatment Associated With Long-Term Complications
3.
Dr. Prerana S. Nesargi's message for Childhood Cancer Awareness Month 2023 is to increase understanding of pediatric oncology.
4.
Food insecurity linked to tumor growth in pediatric neuroblastoma
5.
Promising for Monitoring and Diagnosis of AD is the finger-prick test.
Conferences That Might Interest You
Recommended Articles For You
1.
The Importance of Early Detection in Skin Cancer: Why Regular Skin Exams Matter
2.
Unlocking the Secrets of Ringed Sideroblasts: A New Frontier in Hematology
3.
Adjuvant Atezolizumab in TNBC: What Recent Trials Reveal About Its Role
4.
Beta-2 Microglobulin: Function, Role in Disease & Clinical Significance Explained
5.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
Boost Your Knowledge With These Quizzes
1.
Quiz on Myxedema Coma: Mastering the Emergency Management of Severe Hypothyroidism
2.
Quiz on tertiary Hypothyroidism: Test Your Knowledge About Symptoms and Treatment!
3.
Quiz on Gastroenterology: A Challenging Quiz on Crohn's Disease, Ulcerative Colitis, and Gastrointestinal Disorders
4.
Quiz on Management of Impacted Third Molars: What are the key factors in deciding treatment options for impacted third molars?
5.
Quiz on the Effect of Anesthesia on Brain Cells
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge